Back to search

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile

Data up to Jan 2025

Published2004
Citations159
References33

Total Citations Per Year

Abstract

References (33)

Alzheimer's Disease: Genes, Proteins, and Therapy

2001 • 5,919 citations

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

1996 • 4,118 citations

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

1992 • 1,723 citations

Amyloid, the presenilins and Alzheimer's disease

1997 • 1,370 citations

Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor

1993 • 909 citations

Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

2000 • 880 citations

Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells

1993 • 878 citations

Oxidatively modified proteins in aging and disease1,2 1Guest Editor: Earl Stadtman 2This article is part of a series of reviews on “Oxidatively Modified Proteins in Aging and Disease.” The full list of papers may be found on the homepage of the journal.

2002 • 764 citations

Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death

1997 • 719 citations

A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline

1991 • 656 citations

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

1997 • 640 citations

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

1991 • 625 citations

Microglial response to amyloid plaques in APPsw transgenic mice.

1998 • 580 citations

MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS

1998 • 576 citations

Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro

1992 • 504 citations

N -Acetylaspartate in neuropsychiatric disorders

1995 • 422 citations

REGULATION OF GENE EXPRESSION BY HYPERTONICITY

1997 • 364 citations

Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity

2003 • 326 citations

Probable Alzheimer disease: diagnosis with proton MR spectroscopy.

1995 • 295 citations

MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons

2000 • 277 citations

Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors

1994 • 230 citations

Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice

2000 • 178 citations

N ‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain

1992 • 175 citations

A Proton Magnetic Resonance Spectroscopy Study of Age-related Changes in Frontal Lobe Metabolite Concentrations

2001 • 143 citations

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease

2002 • 111 citations

Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease

1999 • 100 citations

Alzheimer’s disease and total plasma aminothiols

2003 • 88 citations

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.

1998 • 86 citations

Regulation of mammalian brain cell volume

1994 • 84 citations

In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration

2002 • 82 citations

Glutathione Cycle Impairment Mediates Aβ-induced Cell Toxicity

2003 • 33 citations

Choline in the aging brain

2002 • 29 citations

Lack of β-Amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations

1996 • 26 citations

Cited By (0)

Loading...